Orion S.A. (OEC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Adjusted EBITDA for Q1 2026 was $46 million, down 30% year-over-year but above internal expectations, driven by a late-quarter demand surge, especially in the Specialty segment.
Net sales for Q1 2026 were $459.5 million, down 3.8% year-over-year, impacted by lower oil prices and unfavorable product mix, partially offset by higher volumes and favorable FX.
Net loss for Q1 2026 was $9.9 million, compared to net income of $9.1 million in Q1 2025, reflecting lower gross profit and higher interest expense.
The company is leveraging its regional manufacturing footprint and supply chain agility amid global volatility, focusing on cost reductions, inventory management, and margin opportunities.
Demand improvement was broad-based and has continued into April and May, prompting an increase in full-year adjusted EBITDA guidance.
Financial highlights
Adjusted EBITDA for Q1 2026 was $46.1 million, down from $66.2 million year-over-year, but ahead of internal forecasts.
Net sales for Q1 2026 were $459.5 million, down from $477.7 million in Q1 2025.
Free cash outflow for Q1 was $48.5 million, driven by higher working capital needs and $36 million in CapEx.
Adjusted net loss was $6.1 million, compared to adjusted net income of $12.8 million in Q1 2025.
Adjusted diluted EPS was $(0.11), down from $0.22 in Q1 2025.
Outlook and guidance
Full-year adjusted EBITDA guidance raised by $10 million to $170–$210 million, with an expected even split between H1 and H2 due to emission credit timing.
Full-year free cash outflow expected between $25 million and $50 million, assuming oil prices moderate in H2.
Q2 cash flow expected to mirror Q1, with improvement in Q3 and positive cash flow in Q4.
Management expects sufficient liquidity to meet planned capital expenditures and working capital needs, but highlights risks from oil price volatility and geopolitical tensions.
Demand strength in specialties expected to persist through Q2, but visibility beyond that is limited due to geopolitical uncertainty.
Latest events from Orion S.A.
- Proxy covers director elections, pay, audit, risk, and ESG, with strong governance focus.OEC
Proxy filing24 Apr 2026 - 2025 earnings fell but free cash flow stayed positive; 2026 outlook remains cautious.OEC
Q4 202511 Apr 2026 - Proxy covers director elections, compensation, risk oversight, and strong ESG and safety results.OEC
Proxy filing10 Apr 2026 - 2025 saw resilient cash flow, margin stability, and strengthened market leadership in carbon black.OEC
Investor presentation16 Mar 2026 - Commercialization of a unique molecule and free cash flow inflection expected by 2026.OEC
Gabelli Funds' 16th Annual Specialty Chemicals Symposium3 Feb 2026 - Q3 2025 net loss of $67.1M, $80.8M goodwill impairment, and positive free cash flow.OEC
Q3 20253 Feb 2026 - Q2 2024 sales up 4%, but earnings fell as Rubber demand lagged and costs rose.OEC
Q2 20242 Feb 2026 - EU bans and shipping disruptions tighten supply, boosting domestic value and sustainability focus.OEC
Jefferies Global Industrial Conference 202422 Jan 2026 - Earnings growth targets hinge on specialty expansion, supply constraints, and disciplined capital use.OEC
UBS Global Materials Conference22 Jan 2026